Literature DB >> 8919340

Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases.

V Dasappa1, W B Ross, J King, D W King, P R Clingan, D L Morris.   

Abstract

Twenty-two patients with colorectal cancer and synchronous unresectable hepatic metastases were treated by resection the primary tumour with concurrent insertion of an Infusaid infusaport system for regional chemoperfusion (hepatic arterial 20, portal venous 2). Four patients in addition had cryotherapy the liver metastases. Morbidity from the synchronous procedures was minimal. Median survival was 10 months. Four patients with poorly-differentiated tumours had a poor response, with a median survival of 3.75 months.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8919340     DOI: 10.1007/bf00418854

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  21 in total

1.  THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM.

Authors:  C PESTANA; R J REITEMEIER; C G MOERTEL; E S JUDD; M B DOCKERTY
Journal:  Am J Surg       Date:  1964-12       Impact factor: 2.565

2.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

3.  Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices.

Authors:  S A Curley; J L Chase; M S Roh; D C Hohn
Journal:  Surgery       Date:  1993-11       Impact factor: 3.982

4.  Sites of recurrent tumour after 'curative' colorectal surgery: implications for adjuvant therapy.

Authors:  J M Gilbert; I Jeffrey; M Evans; A E Kark
Journal:  Br J Surg       Date:  1984-03       Impact factor: 6.939

5.  A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.

Authors:  D C Hohn; R J Stagg; M A Friedman; J F Hannigan; A Rayner; R J Ignoffo; P Acord; B J Lewis
Journal:  J Clin Oncol       Date:  1989-11       Impact factor: 44.544

6.  Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis.

Authors:  P J Finan; R J Marshall; E H Cooper; G R Giles
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939

7.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

8.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

Review 9.  Hepatic artery chemotherapy for colorectal liver metastases.

Authors:  J L McCall; J O Jorgensen; D L Morris
Journal:  Aust N Z J Surg       Date:  1995-06

10.  A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases.

Authors:  H W Warren; J H Anderson; P O'Gorman; E Kane; D J Kerr; T G Cooke; C S McArdle
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.